Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$120.36
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Axsome Therapeutics Analyst Ratings and Price Targets | NASDAQ:AXSM | Benzinga
Axsome Therapeutics Inc has a consensus price target of $160.24 based on the ratings of 17 analysts. The high is $212 issued by Mizuho on February 26, 2025. The low is $105 issued by UBS on August 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Needham, and Baird on March 6, 2025, March 3, 2025, and March 3, 2025, respectively. With an average price target of $171 between HC Wainwright & Co., Needham, and Baird, there's an implied 42.07% upside for Axsome Therapeutics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Needham
Baird
Morgan Stanley
Mizuho
1calculated from analyst ratings
Analyst Ratings for Axsome Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/06/2025 | Buy Now | 66.17% | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 27.12% | Needham | Ami Fadia62% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 03/03/2025 | Buy Now | 32.93% | Baird | Joel Beatty69% | $132 → $160 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | 57.86% | Morgan Stanley | Vikram Purohit38% | $125 → $190 | Maintains | Overweight | Get Alert |
| 02/26/2025 | Buy Now | 76.14% | Mizuho | Graig Suvannavejh56% | $195 → $212 | Maintains | Outperform | Get Alert |
| 02/25/2025 | Buy Now | 66.17% | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Reiterates | Buy → Buy | Get Alert |
| 02/24/2025 | Buy Now | 27.12% | Needham | Ami Fadia62% | $153 → $153 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | 66.17% | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 66.17% | Truist Securities | Joon Lee77% | $190 → $200 | Maintains | Buy | Get Alert |
| 02/19/2025 | Buy Now | 59.52% | RBC Capital | Leonid Timashev44% | $143 → $192 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | 27.12% | Cantor Fitzgerald | Charles Duncan72% | $153 → $153 | Reiterates | Overweight → Overweight | Get Alert |
| 02/19/2025 | Buy Now | 27.12% | Needham | Ami Fadia62% | $133 → $153 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 32.93% | Wells Fargo | Cerena Chen50% | $140 → $160 | Maintains | Overweight | Get Alert |
| 02/11/2025 | Buy Now | 46.23% | Deutsche Bank | David Hoang40% | → $176 | Initiates | → Buy | Get Alert |
| 02/11/2025 | Buy Now | 38.75% | B of A Securities | Jason Gerberry63% | $143 → $167 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 62.01% | Mizuho | Graig Suvannavejh56% | $137 → $195 | Maintains | Outperform | Get Alert |
| 02/11/2025 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 02/10/2025 | Buy Now | 24.63% | Leerink Partners | Marc Goodman74% | $110 → $150 | Maintains | Outperform | Get Alert |
| 02/10/2025 | Buy Now | 10.5% | Needham | Ami Fadia62% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 02/03/2025 | Buy Now | 13.83% | Mizuho | Graig Suvannavejh56% | $122 → $137 | Maintains | Outperform | Get Alert |
| 02/03/2025 | Buy Now | 57.86% | Truist Securities | Joon Lee77% | $180 → $190 | Maintains | Buy | Get Alert |
| 02/03/2025 | Buy Now | 18.81% | RBC Capital | Brian Abrahams52% | $139 → $143 | Maintains | Outperform | Get Alert |
| 01/31/2025 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $190 | Maintains | Buy | Get Alert |
| 01/29/2025 | Buy Now | 15.49% | RBC Capital | Brian Abrahams52% | $139 → $139 | Maintains | Outperform | Get Alert |
| 01/21/2025 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 10.5% | Needham | Ami Fadia62% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 49.55% | Truist Securities | Joon Lee77% | $150 → $180 | Maintains | Buy | Get Alert |
| 01/06/2025 | Buy Now | 10.5% | Needham | Ami Fadia62% | $133 → $133 | Reiterates | Buy → Buy | Get Alert |
| 12/31/2024 | Buy Now | 1.36% | Mizuho | Graig Suvannavejh56% | $124 → $122 | Maintains | Outperform | Get Alert |
| 12/31/2024 | Buy Now | — | HC Wainwright & Co. | Raghuram Selvaraju43% | — | Reiterates | Buy → Buy | Get Alert |
| 12/30/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 12/12/2024 | Buy Now | 0.53% | Cantor Fitzgerald | Charles Duncan72% | $121 → $121 | Reiterates | Overweight → Overweight | Get Alert |
| 11/27/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/25/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/13/2024 | Buy Now | -3.62% | Baird | Joel Beatty69% | $112 → $116 | Maintains | Outperform | Get Alert |
| 11/13/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 11/12/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 10/04/2024 | Buy Now | 8.84% | RBC Capital | Leonid Timashev44% | $130 → $131 | Maintains | Outperform | Get Alert |
| 09/20/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/16/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/09/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/06/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 09/05/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 09/03/2024 | Buy Now | 16.32% | Wells Fargo | Cerena Chen50% | → $140 | Initiates | → Overweight | Get Alert |
| 08/22/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | -12.76% | UBS | Ashwani Verma48% | $107 → $105 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | 8.01% | RBC Capital | Leonid Timashev44% | $131 → $130 | Maintains | Outperform | Get Alert |
| 08/06/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/06/2024 | Buy Now | -11.93% | B of A Securities | Jason Gerberry63% | $95 → $106 | Upgrade | Neutral → Buy | Get Alert |
| 08/06/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 08/05/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | $130 → $130 | Reiterates | Buy → Buy | Get Alert |
| 07/26/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 07/22/2024 | Buy Now | 8.84% | RBC Capital | Leonid Timashev44% | $131 → $131 | Reiterates | Outperform → Outperform | Get Alert |
| 07/22/2024 | Buy Now | 8.01% | Needham | Ami Fadia62% | → $130 | Initiates | → Buy | Get Alert |
| 07/18/2024 | Buy Now | -21.07% | B of A Securities | Jason Gerberry63% | $97 → $95 | Maintains | Neutral | Get Alert |
| 06/12/2024 | Buy Now | -11.93% | Mizuho | Graig Suvannavejh56% | $106 → $106 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2024 | Buy Now | 8.01% | RBC Capital | Leonid Timashev44% | $127 → $130 | Maintains | Outperform | Get Alert |
| 05/08/2024 | Buy Now | -11.93% | Mizuho | Graig Suvannavejh56% | $109 → $106 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Reiterates | Buy → Buy | Get Alert |
| 05/07/2024 | Buy Now | 3.86% | Citigroup | David Hoang40% | $127 → $125 | Maintains | Buy | Get Alert |
| 05/07/2024 | Buy Now | -6.95% | Baird | Joel Beatty69% | $108 → $112 | Maintains | Outperform | Get Alert |
| 04/29/2024 | Buy Now | -4.45% | Morgan Stanley | Vikram Purohit38% | $90 → $115 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/10/2024 | Buy Now | -11.1% | Cantor Fitzgerald | Charles Duncan72% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
| 04/02/2024 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $190 | Maintains | Buy | Get Alert |
| 03/28/2024 | Buy Now | -9.44% | Mizuho | Graig Suvannavejh56% | $108 → $109 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 24.63% | Truist Securities | Joon Lee77% | → $150 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 6.35% | RBC Capital | Leonid Timashev44% | $123 → $128 | Maintains | Outperform | Get Alert |
| 03/26/2024 | Buy Now | 5.52% | Citigroup | David Hoang40% | $125 → $127 | Maintains | Buy | Get Alert |
| 03/26/2024 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $190 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 03/19/2024 | Buy Now | -10.27% | Baird | Joel Beatty69% | → $108 | Initiates | → Outperform | Get Alert |
| 03/04/2024 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 02/27/2024 | Buy Now | -10.27% | Mizuho | Graig Suvannavejh56% | $112 → $108 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 3.86% | Guggenheim | Yatin Suneja49% | $110 → $125 | Maintains | Buy | Get Alert |
| 02/21/2024 | Buy Now | 2.19% | RBC Capital | Leonid Timashev44% | $126 → $123 | Maintains | Outperform | Get Alert |
| 02/21/2024 | Buy Now | -14.42% | Cantor Fitzgerald | Charles Duncan72% | $108 → $103 | Maintains | Overweight | Get Alert |
| 02/20/2024 | Buy Now | -10.27% | Cantor Fitzgerald | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 02/16/2024 | Buy Now | -6.95% | Mizuho | Graig Suvannavejh56% | $90 → $112 | Maintains | Buy | Get Alert |
| 02/06/2024 | Buy Now | -7.78% | UBS | Ashwani Verma48% | → $111 | Initiates | → Buy | Get Alert |
| 01/25/2024 | Buy Now | 4.69% | RBC Capital | Leonid Timashev44% | → $126 | Initiates | → Outperform | Get Alert |
| 01/22/2024 | Buy Now | -10.27% | Cantor Fitzgerald | Charles Duncan72% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 01/16/2024 | Buy Now | -6.11% | Piper Sandler | David Amsellem69% | $90 → $113 | Maintains | Overweight | Get Alert |
| 12/26/2023 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 12/20/2023 | Buy Now | -10.27% | Cantor Fitzgerald | Charles Duncan72% | $108 → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 12/13/2023 | Buy Now | 3.86% | Citigroup | David Hoang40% | → $125 | Initiates | → Buy | Get Alert |
| 12/12/2023 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $180 → $180 | Reiterates | Buy → Buy | Get Alert |
| 11/07/2023 | Buy Now | -10.27% | Cantor Fitzgerald | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 09/25/2023 | Buy Now | -16.92% | Mizuho | Graig Suvannavejh56% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/28/2023 | Buy Now | -16.92% | Mizuho | Graig Suvannavejh56% | → $100 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | -10.27% | Cantor Fitzgerald | Charles Duncan72% | → $108 | Reiterates | Overweight → Overweight | Get Alert |
| 08/11/2023 | Buy Now | -16.92% | Mizuho | Graig Suvannavejh56% | $95 → $100 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | -32.7% | B of A Securities | Jason Gerberry63% | $59 → $81 | Upgrade | Underperform → Neutral | Get Alert |
| 08/08/2023 | Buy Now | 49.55% | HC Wainwright & Co. | Raghuram Selvaraju43% | $190 → $180 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | -25.22% | Piper Sandler | David Amsellem69% | $70 → $90 | Upgrade | Neutral → Overweight | Get Alert |
| 07/17/2023 | Buy Now | 57.86% | HC Wainwright & Co. | Raghuram Selvaraju43% | $200 → $190 | Maintains | Buy | Get Alert |
| 06/22/2023 | Buy Now | -13.59% | Cantor Fitzgerald | Charles Duncan72% | → $104 | Reiterates | Overweight → Overweight | Get Alert |
| 06/15/2023 | Buy Now | -8.61% | Guggenheim | Yatin Suneja49% | → $110 | Reiterates | Buy → Buy | Get Alert |
| 06/14/2023 | Buy Now | -21.07% | Mizuho | Graig Suvannavejh56% | → $95 | Reiterates | Buy → Buy | Get Alert |
FAQ
What is the target price for Axsome Therapeutics (AXSM) stock?
The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by HC Wainwright & Co. on March 6, 2025. The analyst firm set a price target for $200.00 expecting AXSM to rise to within 12 months (a possible 66.17% upside). 67 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Axsome Therapeutics (AXSM)?
The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by HC Wainwright & Co., and Axsome Therapeutics reiterated their buy rating.
When was the last upgrade for Axsome Therapeutics (AXSM)?
The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.
When was the last downgrade for Axsome Therapeutics (AXSM)?
There is no last downgrade for Axsome Therapeutics.
When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on March 6, 2025 so you should expect the next rating to be made available sometime around March 6, 2026.
Is the Analyst Rating Axsome Therapeutics (AXSM) correct?
While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a reiterated with a price target of $200.00 to $200.00. The current price Axsome Therapeutics (AXSM) is trading at is $120.36, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.